Compare Cassava Sciences Inc (FLNA) vs Sea Limited (SE) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

Sea Limited (SE) trades at $107.47, down 1.67% on the day, with a bullish technical outlook supported by moving averages and strong cash flow growth. Revenue surged to $22.94 billion in 2025, with net income reaching $1.58 billion, though recent earnings misses in Q3 and Q4 2025 temper momentum. Analyst sentiment remains optimistic with a $131 consensus price target, but insider selling and high valuation ratios pose caution.

The stock offers growth potential from expanding Southeast Asian digital services, but risks include competitive pressures and earnings volatility. With a P/E of 43.84, valuation is steep relative to peers, requiring sustained execution to justify upside. Investors should weigh robust fundamentals against near-term headwinds from insider transactions and macroeconomic uncertainty.